Exelixis
EXEL
#1786
Rank
NZ$16.63 B
Marketcap
$58.25
Share price
-0.09%
Change (1 day)
63.17%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company